NCT05362773 2026-01-13A Study of MGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesMacroGenicsPhase 1 Recruiting130 enrolled
NCT06208735 2025-12-15CLIC-2201 for the Treatment of Relapsed/Refractory B Cell MalignanciesBritish Columbia Cancer AgencyPhase 1 Recruiting24 enrolled
NCT06708897 2025-12-05A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad LymphomasLomond Therapeutics Holdings, Inc.Phase 1 Recruiting66 enrolled